Developer of an anti-gene drug platform. The company develops a computational design of modular polymers that bind a specific sequence of DNA.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Out of Business | Completed | Out of Business | ||||
1. Accelerator/Incubator | Completed | Generating Revenue |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Mizied Falah Ph.D | Co-Founder & Chief Technology Officer | ||
Anwar Rayan Ph.D | Co-Founder & Chief Executive Officer |
Growth Rate
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial